跳至主要内容
临床试验/NCT05745961
NCT05745961招募中不适用

Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)

Imperial College London1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
6
试验地点
1
主要终点
The specific and non-specific fractions of the [11C]PBR28 signal in the lungs of healthy individuals and PAH patients.

研究概览

简要总结

The aim of this study is to determine whether there is an increase in the TSPO PET signal (measured with the radioligand [11C]PBR28) in the lungs of patients living with PAH relative to age matched controls. If so, TSPO PET may be a useful technique to non-invasively monitor response to therapy. To do this, we will perform 2 [11C]PBR28 PET scans. The first will quantify the total [11C]PBR28 PET signal. This signal is a combination of the specific signal (VS) and the nonspecific signal (VND). The second scan will be performed following dosing with an unlabelled TSPO ligand. By directly measuring the total [11C]PBR28 signal (scan 1) and the nonspecific [11C]PBR28 signal (scan 2) we can therefore calculate the specific [11C]PBR28 signal, and hence the amount of TSPO in the lung.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
25 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able to provide written informed consent prior to any study mandated procedures.
  • Able to lie comfortably on back for up to 90 minutes at a time.
  • Fertile females (women of childbearing potential) are eligible to participate after a negative highly sensitive pregnancy test, if they are taking a highly effective method of contraception other than the oral contraceptive pill until the end of relevant systemic exposure.
  • Male participants who are fertile are eligible to participate if they are willing to comply with the contraceptive requirements

排除标准

  • Unable to provide informed consent and/or are non-fluent speakers of the English language
  • TT Genotype at the rs6971 locus
  • Clinically-significant renal disease (confirmed by creatinine clearance <30 ml/min per 1.73m2)
  • Clinically-significant liver disease (confirmed by serum transaminases >2 times than upper normal limit)
  • Anaemia confirmed by haemoglobin concentration <10 g/dl
  • Sickle cell disease or thalassaemia
  • History of uncontrolled systemic hypertension
  • Acute infection (including eye, dental, and skin infections)
  • Chronic inflammatory disease including HIV, and Hepatitis B
  • Women of childbearing potential who are pregnant or breastfeeding
  • Patients who have received an Investigational Medicinal Product (IMP) within 5 half-lives of the last dose of the IMP or 1 month (which ever is greater) before the baseline visit
  • Participation in a research study involving significant ionisation radiation within the last 3 years
  • Significant radiation exposure other than dental X-rays in last 1 year
  • Positive Allen's test.

结局指标

主要结局

The specific and non-specific fractions of the [11C]PBR28 signal in the lungs of healthy individuals and PAH patients.

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验